Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

202

الكل

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	91,457,321 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	52,597,003 L.L
L04AB04	AMGEVITA	BioTech	Adalimumab - 40mg/0.8ml	40mg/0.8ml	Injectable solution	38,855,434 L.L
B02BD04	BENEFIX	BioTech	Nonacog alfa (recombinant coagulation factor IX) - 250IU	250IU	Injectable powder for solution+diluent	6,189,491 L.L
L01XX02	ERWINASE	BioTech	Erwinia L-asparaginase - 10,000IU	10,000IU	Injectable lyophilised powder for solution	4,446,519 L.L
L04AB04	AMGEVITA	BioTech	Adalimumab - 40mg/0.8ml	40mg/0.8ml	Injectable solution	38,855,434 L.L
B02BD04	BENEFIX	BioTech	Nonacog alfa (recombinant coagulation factor IX) - 500IU	500IU	Injectable powder for solution+diluent	487,779 L.L
L01XX02	SPECTRILA	BioTech	Asparaginase, recombinant - 10,000IU	10,000IU	Injectable powder for concentrate for solution	21,370,813 L.L
L04AB04	HYRIMOZ	BioTech	Adalimumab - 40mg	40mg	Injectable solution	26,715,144 L.L
B02BD04	BENEFIX	BioTech	Nonacog alfa (recombinant coagulation factor IX) - 1000IU	1,000IU	Injectable powder for solution+diluent	870,681 L.L
L04AB04	HYRIMOZ	BioTech	Adalimumab - 40mg	40mg	Injectable solution	26,715,144 L.L
B02BD04	BENEFIX	BioTech	Nonacog alfa (recombinant coagulation factor IX) - 2000IU	2,000IU	Injectable powder for solution+diluent	1,593,639 L.L
L04AB05	CIMZIA	BioTech	Certolizumab - 200mg/ml	200mg/ml	Injectable solution	72,984,763 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 500IU	500IU	Injectable powder for solution+solvent	1,312,563 L.L
L04AB06	SIMPONI	BioTech	Golimumab - 50mg/0.5ml	50mg/0.5ml	Injectable solution	83,360,986 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 1000IU	1000IU	Injectable powder for solution+solvent	2,832,997 L.L
L04AB06	SIMPONI	BioTech	Golimumab - 100mg/1ml	100mg/1ml	Injectable solution	83,360,986 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 2000IU	2000IU	Injectable powder for solution+solvent	5,665,526 L.L
L04AC02	SIMULECT	BioTech	Basiliximab - 20mg	20mg	Injectable powder + solvent	126,811,740 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	231,551,251 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	5,834,030 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	231,551,251 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 200mg/8ml	200mg/8ml	Injectable concentrate for solution	1,046,598 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 130mg	130mg	Injectable concentrate for solution	222,845,264 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 162mg/0.9ml	162mg/0.9ml	Injectable solution	79,959,812 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 2mg	2mg (100KIU)	Injectable powder for solution+diluent	1,689,135 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 200mg/10ml	200mg/10ml	Injectable concentrated solution	25,362,219 L.L
B02BD08	ARYOSEVEN RT	BioTech	Eptacog alfa - 1mg	1mg	Injectable powder for solution+diluent	16,902,713 L.L
L01CD01	ABRAXANE	BioTech	Paclitaxel Albumin- bound - 5mg/ml	5mg/ml	Injectable powder for suspension	17,850,751 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	47,925,322 L.L

...

202